Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
HDA Recognizes Pharmaceutical and Consumer Product Manufacturers with DIANA Awards
The Healthcare Distribution Alliance (HDA) recognized nine pharmaceutical and consumer product manufacturers with Distribution Industry Awards for Notable Achievements in Healthcare (DIANA Awards) at the 2022 HDA Business and Leadership Conference in Orlando, Fla.
Cardinal Health Transforming the Supply Chain for COVID-19 and the Future
Protecting the steady supply of critical, lifesaving medicines to hospitals, pharmacies, providers and patients is a complex process in normal times. During COVID-19, patient demand for personal protective equipment (PPE) and other products has escalated significantly, adding new and unique challenges for HDA distributor members who are working around the clock to meet the daily healthcare needs of all Americans.
HDA Research Foundation Explores Challenges and Opportunities of Cold Chain Product Distribution
A new publication released by the HDA Research Foundation and Envision Pharma Group — The Future of the U.S. Pharmaceutical Cold Chain — offers strategies to address the remarkable growth of temperature-sensitive products in the healthcare ecosystem — a product class that, as noted in the report, has outpaced non-cold chain therapies by 21 percent between 2018 and 2024.
Faces of the Supply Chain: Distribution Sector Career Pathways
As some of the best minds in distribution convened for the 2024 Distribution Management Conference, HDA spoke with professionals at all stages of their careers to explore paths that led to them to rewarding work. Their insights are featured in the latest installment of the Faces of the Supply Chain video series. In part two of our two-part series, we share some of the valuable perspectives on careers in distribution highlighted during these conversations.
HDA Statement on Proposed Tariffs of Pharmaceutical Products
HDA released a statement in response to President Donald J. Trump’s announcement on pledged tariffs for pharmaceuticals.